- Accesswire•27 days ago
Introduces 2017 Revenue and Unit Guidance for RosettaGX Reveal PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / December 20, 2016 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company ...
- Accesswire•2 months ago
LOS ANGELES, CA / ACCESSWIRE / December 1, 2016 / Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces that Company management ...
- Business Wire•2 months agoRosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering
Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based and other molecular diagnostic testing services, today announced it has entered into definitive agreements with one prominent institutional healthcare investor to purchase an aggregate of 1,095,000 ordinary shares at a purchase price per share of $0.50 and registered convertible debentures in a registered direct offering, as ...
ROSG : Summary for Rosetta Genomics Ltd. - ordinar - Yahoo Finance
Rosetta Genomics Ltd. (ROSG)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.12 x 200|
|Ask||1.19 x 3000|
|Day's Range||0.52 - 0.58|
|52 Week Range||0.41 - 1.60|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.59|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|